The J-Curve Phenomenon in Hypertension

Almost immediately after antihypertensive therapy was proven effective in preventing cardiovascular events, the J-curve issue emerged as a hot topic. The Hypertension Optimal Treatment (HOT) trial attempted to address this question (diastolic blood pressure <80, <85, and <90 mm Hg) but ended up with a post hoc analysis indicating a nadir of 138.5 mm Hg systolic and 82.6 mm Hg diastolic blood pressure. Nevertheless, this observational finding was supported by the results of observational studies in the general population and by post hoc analyses of antihypertensive treatment trials. The currently ongoing Systolic Hypertension Optimal Treatment (SHOT) trial investigates whether the relationship between systolic blood pressure and stroke recurrence is linear or J-shaped by treating systolic blood pressure to <125, <135, and <145 mm Hg in patients with a history of recent stroke. This trial may provide additional but probably inconclusive evidence, because optimal blood pressure might differ between individuals and across outcomes. Nevertheless, a universal beneficial, instead of optimal, level of blood pressure for antihypertensive treatment may exist approximating 130/80 mm Hg and should be investigated by comparing 130/80 mm Hg with 140/90 mm Hg as a target blood pressure in hypertensive patients with the simultaneous use of modern blood pressure measuring techniques, such as home and ambulatory blood pressure monitoring.

[1]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[2]  G. Mancia,et al.  Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. , 2016, European Heart Journal.

[3]  K. Kalantar-Zadeh,et al.  Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. , 2014, JAMA internal medicine.

[4]  Li-sheng Liu,et al.  Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. , 2014, Journal of hypertension.

[5]  M. Woodward,et al.  Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial , 2014, The Lancet Neurology.

[6]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[7]  P. Nilsson,et al.  Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients , 2013, Journal of hypertension.

[8]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[9]  Y. Tzeng,et al.  Blood pressure regulation IX: cerebral autoregulation under blood pressure challenges , 2013, European Journal of Applied Physiology.

[10]  Yan Li,et al.  Albuminuria in relation to the single and combined effects of systolic and diastolic blood pressure in Chinese , 2013, Blood pressure.

[11]  P. Okin,et al.  Impact of lower achieved blood pressure on outcomes in hypertensive patients , 2012, Journal of hypertension.

[12]  D. Grobbee,et al.  Relation Between Blood Pressure and Vascular Events and Mortality in Patients With Manifest Vascular Disease: J-Curve Revisited , 2012, Hypertension.

[13]  L. Ruilope,et al.  Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. , 2011, The New England journal of medicine.

[14]  S. Bangalore,et al.  J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. , 2010, European heart journal.

[15]  C. Cannon,et al.  What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial , 2010, Circulation.

[16]  Robert J. Anderson,et al.  Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial , 2010, Diabetes Care.

[17]  T. Ogihara,et al.  Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study , 2010, Hypertension.

[18]  G. Bakris,et al.  Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.

[19]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[20]  M. Laakso,et al.  Effect of valsartan on the incidence of diabetes and cardiovascular events. , 2010, The New England journal of medicine.

[21]  P. Austin,et al.  Association of Blood Pressure at Hospital Discharge With Mortality in Patients Diagnosed With Heart Failure , 2009, Circulation. Heart failure.

[22]  A. Smith,et al.  Blood Pressure, Dementia and Alzheimer’s Disease: The OPTIMA Longitudinal Study , 2009, Dementia and Geriatric Cognitive Disorders.

[23]  S. Yusuf,et al.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study , 2009, Journal of hypertension.

[24]  石井當男.  Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS) , 2008, Hypertension Research.

[25]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[26]  Gina Soriya,et al.  Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? , 2007 .

[27]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[28]  T. Ogihara,et al.  The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): Protocol, Patient Characteristics, and Blood Pressure during the First 12 Months , 2005, Hypertension Research.

[29]  C. Pepine,et al.  A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial , 2004 .

[30]  Carl J Pepine,et al.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.

[31]  P. Rothwell,et al.  Relationship Between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease , 2003, Stroke.

[32]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[33]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[34]  François Gueyffier,et al.  J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data , 2002, Annals of Internal Medicine.

[35]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[36]  B. Winblad,et al.  Low blood pressure and dementia in elderly people: the Kungsholmen project , 1996, BMJ.

[37]  J. Cutler,et al.  Blood Pressure and Mortality Among Men With Prior Myocardial Infarction , 1995 .

[38]  A. Nissinen,et al.  Change in blood pressure and 5‐year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study , 1994, Journal of hypertension.

[39]  D. E. Grobbee,et al.  J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis , 1994, The Lancet.

[40]  K. Minematsu,et al.  The J‐Curve Phenomenon in Stroke Recurrence , 1993, Stroke.

[41]  R. D'Agostino,et al.  Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. , 1991, BMJ.

[42]  J. Cruickshank.  Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. , 1988, BMJ.

[43]  J. Cruickshank,et al.  BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE , 1987, The Lancet.

[44]  I. Stewart.  RELATION OF REDUCTION IN PRESSURE TO FIRST MYOCARDIAL INFARCTION IN PATIENTS RECEIVING TREATMENT FOR SEVERE HYPERTENSION , 1979, The Lancet.

[45]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[46]  M. Woodward,et al.  Blood pressure variability and outcome after acute intracerebral haemorrhage : a post-hoc analysis of INTERACT 2 , a randomised controlled trial * , 2014 .

[47]  Yutaka Imai,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) , 2014, Hypertension Research.

[48]  T. Ogihara,et al.  The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension , 2009, Hypertension Research.

[49]  G. Moneta.  Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events , 2009 .

[50]  W. Elliott.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2008 .

[51]  S. Kenchaiah,et al.  Cardiac remodeling in systemic hypertension. , 2004, The Medical clinics of North America.

[52]  J. Cutler,et al.  Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. , 1995, Circulation.

[53]  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. , 1970, JAMA.

[54]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.